/>

Pages

Tuesday, February 5, 2019

NEWS 05 FEB 2019

NEWS FROM USA

ANDA Approvals                                                  

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

1 Feb. 2019

Methylphenidate hydrochloride

Cediprof

Ritalin

More than 10

1 Feb. 2019

Baclofen tablets

Eywa pharm 

N/A

More than 10

1 Feb. 2019

Dicyclomine injection

Nexus pharma

Bentyl

Six

1 Feb. 2019

Oxycodone oral solution

Pharma Assoc 

N/A

N/A

 

Tentative ANDA Approvals 

Approval Date

Drug

Company

1 Feb. 2019

Pregabalin

Alkem

1 Feb. 2019

Apixaban

Micro labs

4 Feb. 2019

Dapagliflozin

Teva

4 Feb. 2019

Febuxostat

Torrent

 


 

NEW GENERICS LAUNCHES IN THE US

 DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Clomipramine hydrochloride capsules

Lupin

Anafranil

(Specgx)

$ 96.2 millions

Link

 

GENERIC PATENT LITIGATION

Generic Suboxone (Dr. Reddy’s) Court of Appeals for the Federal Circuit (CAFC) Denies Motion for Rehearing or Rehearing En Banc Following the CAFC’s Ruling Vacating the Preliminary Injunction Granted against Dr. Reddy’s Laboratories

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com

No comments:

Post a Comment